Anti-ARHGAP29 monoclonal antibody

Pre-made anti-ARHGAP29 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ARHGAP29/ARHGAP29 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2351-Ab-1/ GM-Tg-hg-IP2351-Ab-2Anti-Human ARHGAP29 monoclonal antibodyHuman
GM-Tg-rg-IP2351-Ab-1/ GM-Tg-rg-IP2351-Ab-2Anti-Rat ARHGAP29 monoclonal antibodyRat
GM-Tg-mg-IP2351-Ab-1/ GM-Tg-mg-IP2351-Ab-2Anti-Mouse ARHGAP29 monoclonal antibodyMouse
GM-Tg-cynog-IP2351-Ab-1/ GM-Tg-cynog-IP2351-Ab-2Anti-Cynomolgus/ Rhesus macaque ARHGAP29 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2351-Ab-1/ GM-Tg-felg-IP2351-Ab-2Anti-Feline ARHGAP29 monoclonal antibodyFeline
GM-Tg-cang-IP2351-Ab-1/ GM-Tg-cang-IP2351-Ab-2Anti-Canine ARHGAP29 monoclonal antibodyCanine
GM-Tg-bovg-IP2351-Ab-1/ GM-Tg-bovg-IP2351-Ab-2Anti-Bovine ARHGAP29 monoclonal antibodyBovine
GM-Tg-equg-IP2351-Ab-1/ GM-Tg-equg-IP2351-Ab-2Anti-Equine ARHGAP29 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2351-Ab-1/ GM-Tg-hg-IP2351-Ab-2; GM-Tg-rg-IP2351-Ab-1/ GM-Tg-rg-IP2351-Ab-2;
GM-Tg-mg-IP2351-Ab-1/ GM-Tg-mg-IP2351-Ab-2; GM-Tg-cynog-IP2351-Ab-1/ GM-Tg-cynog-IP2351-Ab-2;
GM-Tg-felg-IP2351-Ab-1/ GM-Tg-felg-IP2351-Ab-2; GM-Tg-cang-IP2351-Ab-1/ GM-Tg-cang-IP2351-Ab-2;
GM-Tg-bovg-IP2351-Ab-1/ GM-Tg-bovg-IP2351-Ab-2; GM-Tg-equg-IP2351-Ab-1/ GM-Tg-equg-IP2351-Ab-2
Products NameAnti-ARHGAP29 monoclonal antibody
Formatmab
Target NameARHGAP29
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ARHGAP29 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2351-Ag-1Recombinant multi-species RHG29/ ARHGAP29/ PARG1 protein


    Target information

    Target IDGM-IP2351
    Target NameARHGAP29
    Gene ID9411,214137,310833,708896,479940,101099818,504657,100051002
    Gene Symbol and Synonyms6720461J18Rik,A830014I19,ARHGAP29,B130017I01Rik,PARG1,RGD1306185
    Uniprot AccessionQ52LW3,Q5PQJ5,A7YY57
    Uniprot Entry NameRHG29_HUMAN,RHG29_RAT,RHG29_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000137962
    Target ClassificationN/A

    The target: ARHGAP29, gene name: ARHGAP29, also named as PARG1. Rap1 is a small GTPase that, through effectors, regulates Rho GTPase signaling. These effectors- Rasip1, Radil, and the protein encoded by this gene- translocate to the cell membrane, where they form a multiprotein complex. This complex is necessary for Rap1-induced inhibition of Rho signaling. Defects in this gene may be a cause of nonsyndromic cleft lip with or without cleft palate. [provided by RefSeq, Jun 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.